Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Multicenter, Open Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

NCT02849210 is registered in ClinicalTrials.gov with Roxall Medicina España S.A as lead sponsor.

NCT NCT02849210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Multicenter, Open Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea
Lead sponsor
Roxall Medicina España S.A
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
June 2, 2017
Enrollment
47 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis